A total of 11% of RSV patients experienced a cardiac event, abnormal heart rhythm, heart failure, or ischemic heart disease.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
Editor's Note: CIDRAP's Public Health Practices online database showcases peer-reviewed practices, including useful tools to help others with their planning. This article is one of a biweekly series exploring the development of these practices. We hope that describing the process and context of these practices enhances pandemic planning.
(CIDRAP News) The US Centers for Disease Control and Prevention (CDC) said today that most circulating influenza B viruses tested so far this season don't match this year's vaccine, signaling that two of the three vaccine components are off-target.
(CIDRAP News) European health officials today reported signs of an increasing rate of resistance to oseltamivir (Tamiflu) in Europe's predominant subtype of influenza virus, but they cautioned that the rate seen in isolates tested so far may not reflect the real situation.
(CIDRAP News) – As seasonal influenza makes its annual march across the country, surveillance data from the US Centers for Disease Control and Prevention (CDC) reveals that 23% of the viruses that have been identified belong to a strain that is not included in this season's vaccine.
(CIDRAP News) European officials yesterday reported more evidence that one of the three types of seasonal influenza viruses is showing resistance to oseltamivir (Tamiflu) and said this represents the first clear sign that the resistant variant can spread.
(CIDRAP News) School-based vaccination could be a cost-effective option for preventing influenza in school-age children and their families, according to a recent multistate trial.
Editor's Note: CIDRAP's Promising Practices: Pandemic Influenza Preparedness Tools (www.pandemicpractices.org) online database showcases peer-reviewed practices, including useful tools to help others with their planning. This article is one of a biweekly series exploring the development of these practices. We hope that describing the process and context of these practices enhances pandemic planning.
(CIDRAP News) An early report on the seasonal influenza strains circulating in Europe reveals that some H1N1 viruses show signs of resistance to the antiviral drug oseltamivir, the European Centre for Disease Prevention and Control (ECDC) reported this week.
(CIDRAP News) A recent survey suggests that about a quarter of primary care physicians (PCPs) were still prescribing older antiviral drugs for influenza during the last flu season, despite a federal warning to avoid them because of viral resistance, according to the Centers for Disease Control and Prevention (CDC).
(CIDRAP News) Antiviral medications and vaccines are two tools that many government and health officials hope will stall the spread of an influenza pandemic, but each strategy has daunting challenges, according to a new report from Congress's Government Accountability Office (GAO).
